Cargando…

Risk factors for myopic choroidal neovascularization-related macular atrophy after anti-VEGF treatment

PURPOSE: The study aimed to evaluate risk factors for macular atrophy (MA) associated with myopic choroidal neovascularization (mCNV) during long-term follow-up after intravitreal anti-vascular endothelial growth factor (VEGF) treatment in highly myopic eyes. METHODS: The medical records of patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Ki Woong, Kim, Dong Ik, Kim, Bo Hee, Oh, Baek-Lok, Lee, Eun Kyoung, Yoon, Chang Ki, Park, Un Chul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499232/ https://www.ncbi.nlm.nih.gov/pubmed/36137056 http://dx.doi.org/10.1371/journal.pone.0273613

Ejemplares similares

Progression pattern of myopic maculopathy according to the severity of diffuse chorioretinal atrophy and choroidal thickness
por: Park, Un Chul, et al.
Publicado: (2022)

Decreased choroidal and scleral thicknesses in highly myopic eyes with posterior staphyloma
por: Park, Un Chul, et al.
Publicado: (2021)

The effect of intravitreal brolucizumab on choroidal thickness in patients with neovascular age-related macular degeneration
por: Bae, Ki Woong, et al.
Publicado: (2022)

Morphological parameters of myopic choroidal neovascularization as predictive factors of anti-VEGF treatment response
por: Castellino, Niccolò, et al.
Publicado: (2022)

Prognostic value of myopic disk deformation in myopic choroidal neovascularization: A 6-year follow-up study
por: Han, Ye Eun, et al.
Publicado: (2022)

Indocyanine Green Angiographic Features of Myopic Subfoveal Choroidal Neovascularization as a Prognostic Factor after Photodynamic Therapy
por: Byeon, Suk Ho, et al.
Publicado: (2006)

Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application
por: Zhang, Yan, et al.
Publicado: (2015)

Three cases of macular retinal detachment exacerbated during follow-up with myopic foveoschisis around myopic choroidal neovascularization()()
por: Sayanagi, Kaori, et al.
Publicado: (2023)

Single intravitreal ranibizumab for myopic choroidal neovascularization
por: Nor-Masniwati, Saidin, et al.
Publicado: (2011)

Histology of neovascular myopic macular degeneration
por: Jonas, Shefali B., et al.
Publicado: (2021)

Choroidal Neovascularization Following Epiretinal Membrane Peeling
por: Bae, Ki Woong, et al.
Publicado: (2015)

Spectral domain-optical coherence tomography retinal biomarkers in choroidal neovascularization of multifocal choroiditis, myopic choroidal neovascularization, and idiopathic choroidal neovascularization
por: Gao, Rui, et al.
Publicado: (2021)

Association of Retinal Sensitivity With Optical Coherence Tomography Microstructure in Highly Myopic Patients
por: Park, Un Chul, et al.
Publicado: (2022)

VISUAL ACUITY OUTCOMES OF RANIBIZUMAB TREATMENT IN PATHOLOGIC MYOPIC EYES WITH MACULAR RETINOSCHISIS AND CHOROIDAL NEOVASCULARIZATION
por: Ceklic, Lala, et al.
Publicado: (2017)

Occult choroidal neovascularization after successful macular hole surgery treated with ranibizumab
por: Oh, Ha Na, et al.
Publicado: (2012)

Association between choriocapillaris flow deficit and choroidal neovascularization activity in eyes with myopic choroidal neovascularization
por: Uematsu, Sato, et al.
Publicado: (2021)

Current and emerging treatment options for myopic choroidal neovascularization
por: El Matri, Leila, et al.
Publicado: (2015)

Multimodal imaging and diagnosis of myopic choroidal neovascularization in Caucasians
por: Milani, Paolo, et al.
Publicado: (2016)

Result of intravitreal aflibercept injection for myopic choroidal neovascularization
por: Chen, Shih-Lin, et al.
Publicado: (2021)

Intravitreal aflibercept versus bevacizumab for treatment of myopic choroidal neovascularization
por: Wang, Jia-Kang, et al.
Publicado: (2018)

Anti-Human VEGF Repebody Effectively Suppresses Choroidal Neovascularization and Vascular Leakage
por: Hwang, Da-Eun, et al.
Publicado: (2016)

Perforating scleral vessels adjacent to myopic choroidal neovascularization achieved a poor outcome after intravitreal anti-VEGF therapy
por: Yao, Wangjing, et al.
Publicado: (2022)

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age
por: Karagiannis, Dimitrios, et al.
Publicado: (2017)

Combined Treatment of Photodynamic Therapy and Bevacizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
por: Kim, Hyun Woong, et al.
Publicado: (2011)

Association of macular thickness with parapapillary atrophy in myopic eyes
por: Piao, Helong, et al.
Publicado: (2020)

Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration
por: Hirata, Akira, et al.
Publicado: (2017)

Combined photodynamic therapy and intravitreal bevacizumab as treatment for nonresponsive myopic choroidal neovascularization
por: Chhablani, Jay Kumar
Publicado: (2010)

Anti-vascular endothelial growth factor therapy for the treatment of myopic choroidal neovascularization
por: Tan, Colin S, et al.
Publicado: (2017)

High‑dose aflibercept injection has striking effects on myopic choroidal neovascularization
por: Zhu, Wei, et al.
Publicado: (2023)

Swept-source optical coherence tomography angiography of retinal occlusive vasculitis following brolucizumab administration: a case report
por: Lee, Eun Kyoung, et al.
Publicado: (2022)

Influence of the foveal curvature on myopic macular complications
por: Park, Un Chul, et al.
Publicado: (2019)

Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
por: Barth, T., et al.
Publicado: (2019)

CORRELATION BETWEEN ATROPHY-TRACTION-NEOVASCULARIZATION GRADE FOR MYOPIC MACULOPATHY AND CLINICAL SEVERITY
por: Ruiz-Medrano, Jorge, et al.
Publicado: (2021)

Results of Ranibizumab Treatment of the Myopic Choroidal Neovascular Membrane according to the Axial Length of the Eye
por: Stepanov, Alexandr, et al.
Publicado: (2020)

Ten-Year Outcomes of Intravitreal Bevacizumab for Myopic Choroidal Neovascularization: Analysis of Prognostic Factors
por: Mallone, Fabiana, et al.
Publicado: (2021)

RELATIONSHIP BETWEEN MYOPIC CHOROIDAL NEOVASCULARIZATION ACTIVITY AND PERFORATING SCLERAL VESSELS IN HIGH MYOPIA
por: Ruiz-Medrano, Jorge, et al.
Publicado: (2022)

An ImageJ macro tool for OCTA-based quantitative analysis of Myopic Choroidal neovascularization
por: Deshpande, Aadit, et al.
Publicado: (2023)

Choroidal Neovascularization Regression on Fluorescein Angiography after VEGF Blockade
por: Do, Diana V., et al.
Publicado: (2012)

Suspension of Anti-VEGF Treatment Does Not Affect Expansion of RPE Atrophy in Neovascular Age-Related Macular Degeneration
por: Chujo, Shinichiro, et al.
Publicado: (2023)

Closure of Recalcitrant Macular Hole after Choroidal Neovascularization
por: Ilhan, Cagri, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i60ljld1bm80l321fv2nl3tvuc